EPIMINDER LIMITED (EPI)
AI Coverage Rating: Active
ASX AI Signals has generated 5 signal for EPI during the last 90 days, indicating active trading activity and ongoing AI monitoring
Latest EPI Signals | |
| 30/06/2026 | SELL |
| 07/05/2026 | SELL |
| 20/04/2026 | SELL |
EPI Share Price | |
| Current Price | $0.360 |
| 52 Week High | $1.310 |
| 52 Week Low: | $0.315 |
| Trading at (% of 52 Week High) | 27.48% |
Business Overview
Epiminder Limited (ASX: EPI) is a technology company that provides cloud-based digital health solutions. It focuses on improving healthcare management through software that supports clinical trial operations and patient data management. The company's platform aims to enhance safety and efficiency in the pharmaceutical and biotechnology industries.
ASX Sector Overview
Sector: Health Care Equipment & Services
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
Latest AI Recommendation
The SELL recommendation for EPIMINDER LIMITED (EPI) is supported by technical indicators suggesting downward momentum and potential overvaluation at the current price of 0.3150. Market conditions and sector performance also align with a bearish outlook.
Latest EPIMINDER LIMITED(EPI) News
Unlock All ASX AI Signals
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial